๐๏ธ๐๏ธ๐๏ธ ๏ธ ๐๐ข๐ ๐๐๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐ก๐๐๐ซ๐ญ ๐จ๐ ๐๐๐ง๐๐๐'๐ฌ ๐๐๐ฉ๐ข๐ญ๐๐ฅ! ๐ ๐๐'๐ซ๐ ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐๐ ๐ญ๐จ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐๐ญ ๐ฐ๐'๐ซ๐ ๐ฅ๐๐ฎ๐ง๐๐ก๐ข๐ง๐ ๐ ๐ฉ๐จ๐๐๐๐ฌ๐ญ ๐ฌ๐๐ซ๐ข๐๐ฌ ๐ฌ๐ญ๐ซ๐๐ข๐ ๐ก๐ญ ๐๐ซ๐จ๐ฆ ๐๐ญ๐ญ๐๐ฐ๐, ๐๐ซ๐จ๐๐๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐๐๐. ๐๐ก๐ข๐ฌ ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ข๐ฌย ๐ฒ๐จ๐ฎ๐ซ ๐๐ฅ๐ฅ-๐๐๐๐๐ฌ๐ฌ ๐ฉ๐๐ฌ๐ฌ ๐ญ๐จ ๐ ๐๐ฎ๐ซ๐๐ญ๐๐ ๐ฌ๐๐ฅ๐๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ ๐ฌ๐ก๐จ๐ซ๐ญ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฅ๐ข๐ง๐ข๐๐ข๐๐ง ๐ญ๐ก๐จ๐ฎ๐ ๐ก๐ญ ๐ฅ๐๐๐๐๐ซ๐ฌ ๐๐ง๐ ๐ ๐๐ฆ๐ ๐๐ก๐๐ง๐ ๐๐ซ๐ฌ ๐ฐ๐ก๐จ ๐๐ซ๐ ๐ฌ๐ก๐๐ฉ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ง๐ ๐๐๐ฒ๐จ๐ง๐. ๐๐ช๐ฃ๐ ๐๐ฃ, ๐ฉ๐ช๐ง๐ฃ ๐ช๐ฅ ๐ฉ๐๐ ๐ซ๐ค๐ก๐ช๐ข๐, ๐๐ฃ๐ ๐ฉ๐ง๐๐ฃ๐จ๐๐ค๐ง๐ข ๐ฉ๐ค๐๐๐ฉ๐๐๐ง.ย ๐ง #๐พ๐๐พ2023 #๐๐ค๐๐๐๐จ๐ฉ #๐๐ฉ๐ฉ๐๐ฌ๐ ๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC ๐ก ๐ก ๐กEnsuring immunization of structurally disadvantaged populations: Black People and other people of colour Podcast Learning objectives โข Describe how race-disaggregated data can allow for more targeted, community-specific interventions. โข Apply novel community-specific work to engage communities to support immunization. โข Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives. For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue. About Dr.Sonia Anand MD, PhD, FRCPC Professor of Medicine and Epidemiology, McMaster Senior Scientist Population Health Research Institute Tier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular Disease Heart and Stroke Chair in Population Health Associate Chair of Equity and Diversity, Department of Medicine Director of Chanchlani Research Centre Dr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Womenโs Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease. ๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 2: A Conversation with Dr.Wayne Ghesquiere MD, FRCPC ๐ก ๐ก ๐กLong-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination Podcast Learning objectives โข Discuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination. โข Explain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster. โข Evaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years. โข Analyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster. โข Incorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies. โข Communicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccine About Dr.Wayne Esquire MD, FRCPC Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA. Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases. Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in itโs 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria. Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others. ๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 3: A Conversation with Dr. Juthaporn Cowan, MD, FRCPC ๐ก ๐ก ๐กManagement of COVID-19 in immunocompromised patients: Are you up to date? This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies. Podcast Learning Objectives โข Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS โ CoV-2. โข Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies. โข Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context. About Dr. Juthaporn Cowan, MD, FRCPC Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital. Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa
๐๏ธ๐๏ธ๐๏ธ ๏ธ ๐๐ข๐ ๐๐๐ฐ๐ฌ ๐๐ซ๐จ๐ฆ ๐ญ๐ก๐ ๐ก๐๐๐ซ๐ญ ๐จ๐ ๐๐๐ง๐๐๐'๐ฌ ๐๐๐ฉ๐ข๐ญ๐๐ฅ! ๐
๐๐'๐ซ๐ ๐ญ๐ก๐ซ๐ข๐ฅ๐ฅ๐๐ ๐ญ๐จ ๐๐ง๐ง๐จ๐ฎ๐ง๐๐ ๐ญ๐ก๐๐ญ ๐ฐ๐'๐ซ๐ ๐ฅ๐๐ฎ๐ง๐๐ก๐ข๐ง๐ ๐ ๐ฉ๐จ๐๐๐๐ฌ๐ญ ๐ฌ๐๐ซ๐ข๐๐ฌ ๐ฌ๐ญ๐ซ๐๐ข๐ ๐ก๐ญ ๐๐ซ๐จ๐ฆ ๐๐ญ๐ญ๐๐ฐ๐, ๐๐ซ๐จ๐๐๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐๐๐.
๐๐ก๐ข๐ฌ ๐๐ฉ๐ข๐ฌ๐จ๐๐ ๐ข๐ฌย ๐ฒ๐จ๐ฎ๐ซ ๐๐ฅ๐ฅ-๐๐๐๐๐ฌ๐ฌ ๐ฉ๐๐ฌ๐ฌ ๐ญ๐จ ๐ ๐๐ฎ๐ซ๐๐ญ๐๐ ๐ฌ๐๐ฅ๐๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐ ๐ฌ๐ก๐จ๐ซ๐ญ ๐๐จ๐ง๐ฏ๐๐ซ๐ฌ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐ฅ๐ข๐ง๐ข๐๐ข๐๐ง ๐ญ๐ก๐จ๐ฎ๐ ๐ก๐ญ ๐ฅ๐๐๐๐๐ซ๐ฌ ย ๐๐ง๐ ๐ ๐๐ฆ๐ ๐๐ก๐๐ง๐ ๐๐ซ๐ฌ ๐ฐ๐ก๐จ ๐๐ซ๐ ๐ฌ๐ก๐๐ฉ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐ฉ๐ฎ๐๐ฅ๐ข๐ ๐ก๐๐๐ฅ๐ญ๐ก ๐๐ง๐ ๐๐๐ฒ๐จ๐ง๐.
๐๐ช๐ฃ๐ ๐๐ฃ, ๐ฉ๐ช๐ง๐ฃ ๐ช๐ฅ ๐ฉ๐๐ ๐ซ๐ค๐ก๐ช๐ข๐, ๐๐ฃ๐ ๐ฉ๐ง๐๐ฃ๐จ๐๐ค๐ง๐ข ๐ฉ๐ค๐๐๐ฉ๐๐๐ง.ย ๐ง #๐พ๐๐พ2023 #๐๐ค๐๐๐๐จ๐ฉ #๐๐ฉ๐ฉ๐๐ฌ๐
ย
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC
๐ก ๐ก ๐กEnsuring immunization of structurally disadvantaged populations: Black People and other people of colour
ย
Podcast Learning objectives
ย
For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.
ย
About Dr.Sonia Anand MD, PhD, FRCPC
ย
Dr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Womenโs Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 2: A Conversation with ย Dr.Wayne Ghesquiere MD, FRCPC ย
๐ก ๐ก ๐กLong-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination ย
ย
Podcast Learning objectives ย
About Dr.Wayne Ghesquire MD, FRCPC
Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA. ย
Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases.
Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in itโs 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria.
Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.
ย
ย
๐๏ธ๐๏ธ๐๏ธ MINI EPISODE 3: A Conversation ย with Dr. Juthaporn Cowan, MD, FRCPC
๐ก ๐ก ๐กManagement of COVID-19 in immunocompromised patients: Are you up to date?
ย
This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.
ย
Podcast Learning Objectives ย
ย
About Dr. Juthaporn Cowan, MD, FRCPC
Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute ย
Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.
Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa
ย
ย
ย
ย